Question to the Department for Digital, Culture, Media & Sport:

To ask the Secretary of State for Culture, Media and Sport, what discussions the Department has had with (a) the Medicines and Healthcare products Regulatory Agency and (b) the Gambling Commission on (i) the responsibilities of gambling operators to warn customers about medication-induced impulse control disorders, including from dopamine agonists, and (ii) whether operators should (A) ask about use of high-risk medications and (B) provide tailored safer gambling tools for those at higher risk.

The Department has not engaged with the Medicines and Healthcare products Regulatory Agency or the Gambling Commission regarding this matter. However, DCMS officials worked with the Gambling Commission to develop their Customer Interaction guidance and vulnerability statement, which sets out how operators should support vulnerable customers, including those who are taking medication which may increase risk-taking.